The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Age-Related Macular Degeneration (AMD) AI Screening System Market Research Report 2025
Synopsis
Age-related macular degeneration (AMD) represents one of leading cause of visual impairment in developed countries and a major target for AI-based approaches. The analysis of AMD data is mainly based on optical coherence tomography(OCT) images; thus, image segmentation is a fundamental step for accurately recognizing retinal structures. Many unsupervised AI-based segmentation algorithms have been developed, providing very high performance in detecting retinal features. These algorithms are useful not only for assessing the integrity of retinal structures, but also for localizing and quantifying retinal fluids during follow-up.
The global Age-Related Macular Degeneration (AMD) AI Screening System market was valued at US$ 45.2 million in 2023 and is anticipated to reach US$ 3092 million by 2030, witnessing a CAGR of 81.8% during the forecast period 2024-2030.
The age-related macular degeneration (AMD) market trends are shaping the growth of the market. For instance rise in the adoption of age-related macular degeneration drugs (AMD) among the geriatric population suffering from age-related macular degeneration (AMD) drives the growth of the age-related macular degeneration (AMD) market size. For instance, according to the 2022 factsheet of World Health Organization, by 2030, 1 in 6 people in the world is projected to be aged 60 years or over, indicating a potential increase in the age-related macular degeneration (AMD) market size.
This report aims to provide a comprehensive presentation of the global market for Age-Related Macular Degeneration (AMD) AI Screening System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Age-Related Macular Degeneration (AMD) AI Screening System.
The Age-Related Macular Degeneration (AMD) AI Screening System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Age-Related Macular Degeneration (AMD) AI Screening System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Age-Related Macular Degeneration (AMD) AI Screening System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health
Acer Medical
Segment by Type
Hardware
Software
Segment by Application
Medical Institutions
Great Health Scene
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Age-Related Macular Degeneration (AMD) AI Screening System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Age-related macular degeneration (AMD) represents one of leading cause of visual impairment in developed countries and a major target for AI-based approaches. The analysis of AMD data is mainly based on optical coherence tomography(OCT) images; thus, image segmentation is a fundamental step for accurately recognizing retinal structures. Many unsupervised AI-based segmentation algorithms have been developed, providing very high performance in detecting retinal features. These algorithms are useful not only for assessing the integrity of retinal structures, but also for localizing and quantifying retinal fluids during follow-up.
The global Age-Related Macular Degeneration (AMD) AI Screening System market was valued at US$ 45.2 million in 2023 and is anticipated to reach US$ 3092 million by 2030, witnessing a CAGR of 81.8% during the forecast period 2024-2030.
The age-related macular degeneration (AMD) market trends are shaping the growth of the market. For instance rise in the adoption of age-related macular degeneration drugs (AMD) among the geriatric population suffering from age-related macular degeneration (AMD) drives the growth of the age-related macular degeneration (AMD) market size. For instance, according to the 2022 factsheet of World Health Organization, by 2030, 1 in 6 people in the world is projected to be aged 60 years or over, indicating a potential increase in the age-related macular degeneration (AMD) market size.
This report aims to provide a comprehensive presentation of the global market for Age-Related Macular Degeneration (AMD) AI Screening System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Age-Related Macular Degeneration (AMD) AI Screening System.
The Age-Related Macular Degeneration (AMD) AI Screening System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Age-Related Macular Degeneration (AMD) AI Screening System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Age-Related Macular Degeneration (AMD) AI Screening System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health
Acer Medical
Segment by Type
Hardware
Software
Segment by Application
Medical Institutions
Great Health Scene
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Age-Related Macular Degeneration (AMD) AI Screening System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hardware
1.2.3 Software
1.3 Market by Application
1.3.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Institutions
1.3.3 Great Health Scene
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Perspective (2019-2030)
2.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Growth Trends by Region
2.2.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Age-Related Macular Degeneration (AMD) AI Screening System Historic Market Size by Region (2019-2024)
2.2.3 Age-Related Macular Degeneration (AMD) AI Screening System Forecasted Market Size by Region (2025-2030)
2.3 Age-Related Macular Degeneration (AMD) AI Screening System Market Dynamics
2.3.1 Age-Related Macular Degeneration (AMD) AI Screening System Industry Trends
2.3.2 Age-Related Macular Degeneration (AMD) AI Screening System Market Drivers
2.3.3 Age-Related Macular Degeneration (AMD) AI Screening System Market Challenges
2.3.4 Age-Related Macular Degeneration (AMD) AI Screening System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Age-Related Macular Degeneration (AMD) AI Screening System Players by Revenue
3.1.1 Global Top Age-Related Macular Degeneration (AMD) AI Screening System Players by Revenue (2019-2024)
3.1.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Players (2019-2024)
3.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Age-Related Macular Degeneration (AMD) AI Screening System Revenue
3.4 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Concentration Ratio
3.4.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age-Related Macular Degeneration (AMD) AI Screening System Revenue in 2023
3.5 Global Key Players of Age-Related Macular Degeneration (AMD) AI Screening System Head office and Area Served
3.6 Global Key Players of Age-Related Macular Degeneration (AMD) AI Screening System, Product and Application
3.7 Global Key Players of Age-Related Macular Degeneration (AMD) AI Screening System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Age-Related Macular Degeneration (AMD) AI Screening System Breakdown Data by Type
4.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Historic Market Size by Type (2019-2024)
4.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Forecasted Market Size by Type (2025-2030)
5 Age-Related Macular Degeneration (AMD) AI Screening System Breakdown Data by Application
5.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Historic Market Size by Application (2019-2024)
5.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size (2019-2030)
6.2 North America Age-Related Macular Degeneration (AMD) AI Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024)
6.4 North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size (2019-2030)
7.2 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024)
7.4 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size (2019-2030)
8.2 Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2019-2024)
8.4 Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Age-Related Macular Degeneration (AMD) AI Screening System Market Size (2019-2030)
9.2 Latin America Age-Related Macular Degeneration (AMD) AI Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024)
9.4 Latin America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size (2019-2030)
10.2 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024)
10.4 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Airdoc Technology
11.1.1 Airdoc Technology Company Details
11.1.2 Airdoc Technology Business Overview
11.1.3 Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Introduction
11.1.4 Airdoc Technology Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
11.1.5 Airdoc Technology Recent Development
11.2 Digital Diagnostics
11.2.1 Digital Diagnostics Company Details
11.2.2 Digital Diagnostics Business Overview
11.2.3 Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Introduction
11.2.4 Digital Diagnostics Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
11.2.5 Digital Diagnostics Recent Development
11.3 Eyenuk
11.3.1 Eyenuk Company Details
11.3.2 Eyenuk Business Overview
11.3.3 Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Introduction
11.3.4 Eyenuk Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
11.3.5 Eyenuk Recent Development
11.4 RetinaLyze System
11.4.1 RetinaLyze System Company Details
11.4.2 RetinaLyze System Business Overview
11.4.3 RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Introduction
11.4.4 RetinaLyze System Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
11.4.5 RetinaLyze System Recent Development
11.5 Optomed
11.5.1 Optomed Company Details
11.5.2 Optomed Business Overview
11.5.3 Optomed Age-Related Macular Degeneration (AMD) AI Screening System Introduction
11.5.4 Optomed Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
11.5.5 Optomed Recent Development
11.6 Sibionics Technology
11.6.1 Sibionics Technology Company Details
11.6.2 Sibionics Technology Business Overview
11.6.3 Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Introduction
11.6.4 Sibionics Technology Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
11.6.5 Sibionics Technology Recent Development
11.7 Aeye Health
11.7.1 Aeye Health Company Details
11.7.2 Aeye Health Business Overview
11.7.3 Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Introduction
11.7.4 Aeye Health Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
11.7.5 Aeye Health Recent Development
11.8 VUNO
11.8.1 VUNO Company Details
11.8.2 VUNO Business Overview
11.8.3 VUNO Age-Related Macular Degeneration (AMD) AI Screening System Introduction
11.8.4 VUNO Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
11.8.5 VUNO Recent Development
11.9 Medimaging Integrated Solution
11.9.1 Medimaging Integrated Solution Company Details
11.9.2 Medimaging Integrated Solution Business Overview
11.9.3 Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Introduction
11.9.4 Medimaging Integrated Solution Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
11.9.5 Medimaging Integrated Solution Recent Development
11.10 EyRIS (SELENA+)
11.10.1 EyRIS (SELENA+) Company Details
11.10.2 EyRIS (SELENA+) Business Overview
11.10.3 EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Introduction
11.10.4 EyRIS (SELENA+) Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
11.10.5 EyRIS (SELENA+) Recent Development
11.11 Vistel
11.11.1 Vistel Company Details
11.11.2 Vistel Business Overview
11.11.3 Vistel Age-Related Macular Degeneration (AMD) AI Screening System Introduction
11.11.4 Vistel Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
11.11.5 Vistel Recent Development
11.12 RETINA-AI Health
11.12.1 RETINA-AI Health Company Details
11.12.2 RETINA-AI Health Business Overview
11.12.3 RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Introduction
11.12.4 RETINA-AI Health Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
11.12.5 RETINA-AI Health Recent Development
11.13 Acer Medical
11.13.1 Acer Medical Company Details
11.13.2 Acer Medical Business Overview
11.13.3 Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Introduction
11.13.4 Acer Medical Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
11.13.5 Acer Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hardware
Table 3. Key Players of Software
Table 4. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Region (2019-2024)
Table 8. Global Age-Related Macular Degeneration (AMD) AI Screening System Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Region (2025-2030)
Table 10. Age-Related Macular Degeneration (AMD) AI Screening System Market Trends
Table 11. Age-Related Macular Degeneration (AMD) AI Screening System Market Drivers
Table 12. Age-Related Macular Degeneration (AMD) AI Screening System Market Challenges
Table 13. Age-Related Macular Degeneration (AMD) AI Screening System Market Restraints
Table 14. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Players (2019-2024)
Table 16. Global Top Age-Related Macular Degeneration (AMD) AI Screening System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-Related Macular Degeneration (AMD) AI Screening System as of 2023)
Table 17. Ranking of Global Top Age-Related Macular Degeneration (AMD) AI Screening System Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Age-Related Macular Degeneration (AMD) AI Screening System Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Age-Related Macular Degeneration (AMD) AI Screening System, Headquarters and Area Served
Table 20. Global Key Players of Age-Related Macular Degeneration (AMD) AI Screening System, Product and Application
Table 21. Global Key Players of Age-Related Macular Degeneration (AMD) AI Screening System, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Type (2019-2024)
Table 25. Global Age-Related Macular Degeneration (AMD) AI Screening System Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Type (2025-2030)
Table 27. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Application (2019-2024)
Table 29. Global Age-Related Macular Degeneration (AMD) AI Screening System Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Application (2025-2030)
Table 31. North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2025-2030) & (US$ Million)
Table 46. Airdoc Technology Company Details
Table 47. Airdoc Technology Business Overview
Table 48. Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product
Table 49. Airdoc Technology Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024) & (US$ Million)
Table 50. Airdoc Technology Recent Development
Table 51. Digital Diagnostics Company Details
Table 52. Digital Diagnostics Business Overview
Table 53. Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product
Table 54. Digital Diagnostics Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024) & (US$ Million)
Table 55. Digital Diagnostics Recent Development
Table 56. Eyenuk Company Details
Table 57. Eyenuk Business Overview
Table 58. Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product
Table 59. Eyenuk Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024) & (US$ Million)
Table 60. Eyenuk Recent Development
Table 61. RetinaLyze System Company Details
Table 62. RetinaLyze System Business Overview
Table 63. RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product
Table 64. RetinaLyze System Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024) & (US$ Million)
Table 65. RetinaLyze System Recent Development
Table 66. Optomed Company Details
Table 67. Optomed Business Overview
Table 68. Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product
Table 69. Optomed Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024) & (US$ Million)
Table 70. Optomed Recent Development
Table 71. Sibionics Technology Company Details
Table 72. Sibionics Technology Business Overview
Table 73. Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product
Table 74. Sibionics Technology Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024) & (US$ Million)
Table 75. Sibionics Technology Recent Development
Table 76. Aeye Health Company Details
Table 77. Aeye Health Business Overview
Table 78. Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product
Table 79. Aeye Health Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024) & (US$ Million)
Table 80. Aeye Health Recent Development
Table 81. VUNO Company Details
Table 82. VUNO Business Overview
Table 83. VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product
Table 84. VUNO Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024) & (US$ Million)
Table 85. VUNO Recent Development
Table 86. Medimaging Integrated Solution Company Details
Table 87. Medimaging Integrated Solution Business Overview
Table 88. Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product
Table 89. Medimaging Integrated Solution Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024) & (US$ Million)
Table 90. Medimaging Integrated Solution Recent Development
Table 91. EyRIS (SELENA+) Company Details
Table 92. EyRIS (SELENA+) Business Overview
Table 93. EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product
Table 94. EyRIS (SELENA+) Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024) & (US$ Million)
Table 95. EyRIS (SELENA+) Recent Development
Table 96. Vistel Company Details
Table 97. Vistel Business Overview
Table 98. Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product
Table 99. Vistel Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024) & (US$ Million)
Table 100. Vistel Recent Development
Table 101. RETINA-AI Health Company Details
Table 102. RETINA-AI Health Business Overview
Table 103. RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product
Table 104. RETINA-AI Health Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024) & (US$ Million)
Table 105. RETINA-AI Health Recent Development
Table 106. Acer Medical Company Details
Table 107. Acer Medical Business Overview
Table 108. Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product
Table 109. Acer Medical Revenue in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024) & (US$ Million)
Table 110. Acer Medical Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Age-Related Macular Degeneration (AMD) AI Screening System Picture
Figure 2. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Type: 2023 VS 2030
Figure 4. Hardware Features
Figure 5. Software Features
Figure 6. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Application: 2023 VS 2030
Figure 8. Medical Institutions Case Studies
Figure 9. Great Health Scene Case Studies
Figure 10. Age-Related Macular Degeneration (AMD) AI Screening System Report Years Considered
Figure 11. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Region: 2023 VS 2030
Figure 14. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Players in 2023
Figure 15. Global Top Age-Related Macular Degeneration (AMD) AI Screening System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-Related Macular Degeneration (AMD) AI Screening System as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Age-Related Macular Degeneration (AMD) AI Screening System Revenue in 2023
Figure 17. North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Country (2019-2030)
Figure 19. United States Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Country (2019-2030)
Figure 23. Germany Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Region (2019-2030)
Figure 31. China Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Country (2019-2030)
Figure 39. Mexico Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Country (2019-2030)
Figure 43. Turkey Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. UAE Age-Related Macular Degeneration (AMD) AI Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Airdoc Technology Revenue Growth Rate in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
Figure 47. Digital Diagnostics Revenue Growth Rate in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
Figure 48. Eyenuk Revenue Growth Rate in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
Figure 49. RetinaLyze System Revenue Growth Rate in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
Figure 50. Optomed Revenue Growth Rate in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
Figure 51. Sibionics Technology Revenue Growth Rate in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
Figure 52. Aeye Health Revenue Growth Rate in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
Figure 53. VUNO Revenue Growth Rate in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
Figure 54. Medimaging Integrated Solution Revenue Growth Rate in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
Figure 55. EyRIS (SELENA+) Revenue Growth Rate in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
Figure 56. Vistel Revenue Growth Rate in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
Figure 57. RETINA-AI Health Revenue Growth Rate in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
Figure 58. Acer Medical Revenue Growth Rate in Age-Related Macular Degeneration (AMD) AI Screening System Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
